Earnings Estimates Rising for Century (CENX): Will It Gain?

Century Aluminum (CENX) has experienced significant upward revisions in its earnings estimates, leading to a Zacks Rank #1 (Strong Buy). Analysts have increased current-quarter EPS estimates by 8.64% to $0.88 (+91.3% YoY) and full-year estimates by 11.65% to $2.30 over the past 30 days, driven by growing optimism. This positive trend in analyst sentiment and improving earnings outlook has already contributed to a 12.2% stock price increase for CENX in the last four weeks, indicating potential for further upside.

Analysis

Century Aluminum (CENX) is experiencing a significant positive shift in analyst sentiment, primarily driven by upward revisions to its earnings estimates. Over the last 30 days, the consensus earnings per share (EPS) estimate for the current quarter has increased by 8.64% to $0.88, which represents a substantial 91.3% year-over-year growth projection. Similarly, the full-year consensus EPS estimate has been revised upward by 11.65% to $2.30. This optimism, attributed to one analyst raising estimates without any opposing revisions, has contributed to a 12.2% increase in the stock's price over the past four weeks. However, it is critical to note that despite the recent upward revision, the full-year EPS forecast of $2.30 still signifies a 30.1% decline compared to the previous year. The positive estimate trend has resulted in the company receiving a Zacks Rank #1 (Strong Buy), a rating system that historically correlates with near-term stock outperformance.

Key Decisions for Investors

• Investors with a short-term, momentum-focused strategy could view the recent 12.2% stock price appreciation and strong upward quarterly earnings revisions as a bullish signal.
• Caution is warranted due to the significant contradiction between the strong near-term quarterly growth (+91.3% YoY) and the projected full-year earnings decline (-30.1% YoY), which may indicate underlying challenges or a tough prior-year comparison.
• Given that the positive estimate revisions stem from a single analyst, it is prudent to monitor for broader consensus changes from other covering analysts to validate the improving outlook before committing significant capital.